0
Sign In  | Subscribe
16 August 2005, Vol 143, No. 4>
Summaries for Patients | 16 August 2005

Estimating Outcome in Patients with HIV-Related Lymphoma FREE

[+] Article and Author Information

The summary below is from the full report titled, “A Prognostic Index for Systemic AIDS-Related Non-Hodgkin Lymphoma Treated in the Era of Highly Active Antiretroviral Therapy.” It is in the 16 August 2005 issue of Annals of Internal Medicine (volume 143, pages 265-273). The authors are M. Bower, B. Gazzard, S. Mandalia, T. Newsom-Davis, C. Thirlwell, T. Dhillon, A.M. Young, T. Powles, A. Gaya, M. Nelson, and J. Stebbing.


Ann Intern Med. 2005;143(4):I-28. doi:10.7326/0003-4819-143-4-200508160-00003
Text Size: A A A

What is the problem and what is known about it so far?

Human immunodeficiency virus (HIV) is the cause of AIDS, an illness that interferes with the ability to fight off infection and certain types of cancer. Since 1996, combinations of drugs, known as highly active antiretroviral therapy, or HAART, have been prescribed to decrease infections and cancer and lengthen life in many people with AIDS.

Lymphoma is a type of cancer that develops in lymph nodes, collections of immune cells that are present throughout the body. Lymphoma occurs in people who do not have HIV infection or AIDS, but it is more common in people with HIV or AIDS than in the general population.

The International Prognostic Index (IPI) is an index that helps doctors to predict survival of people with lymphoma. The IPI considers patient age, cancer stage, and laboratory tests. It is not known how well the IPI predicts survival in people with HIV-related lymphoma who are receiving HAART. Since HIV-related lymphoma is a common complication of HIV infection, it would be helpful to have a way to predict how patients with this cancer will do.

Why did the researchers do this particular study?

To see whether the IPI or other factors could help to predict survival in people with HIV-related lymphoma.

Who was studied?

111 patients with HIV infection and lymphoma diagnosed since 1996.

How was the study done?

The researchers collected information on the factors that make up the IPI, other patient characteristics, and laboratory values and developed mathematical models to see which combination of factors did the best job of predicting how long people lived.

What did the researchers find?

The IPI index plus a laboratory value called CD4 cell count could separate patients into 4 groups that had 1-year survival rates of 82%, 47%, 20%, and 15%.

What were the limitations of the study?

The study included only 111 patients who were taking a variety of different combinations of HIV drugs. It was not able to determine whether the type of HIV treatment was related to survival.

What are the implications of the study?

The IPI and CD4 cell count can help doctors predict the prognosis of patients with HIV-related lymphoma.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general jounals
BMJ 2010;341:c5893-c1494.

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Advertisement

Related Content

Customize your page view by dragging & repositioning the boxes below.

Topic Collections
PubMed Articles
Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma.
International journal of hematology Issue date: 2013 Apr 21
Poor outcome of HIV-infected patients with plasmablastic lymphoma: results from the German AIDS-related lymphoma cohort study.
AIDS (London, England) Issue date: 2013 Mar 13

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)